Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023

Shares of Aurobindo Pharma hit a two-year high of Rs 872.95, as they gained 4 per cent on the BSE in Monday’s intra-day trade after the company got US drug regulator’s approval for skin and bone infection drug. The stock was trading at its highest level since August 2021. Thus far in calendar year 2023,… Continue reading Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023

UPL slips 5%, hits over 2-year low on weak June quarter results

Shares of UPL hit an over two-year low of Rs 590.10, as they slipped 5 per cent on the BSE in Thursday’s intra-day trade after the company reported a weak set of numbers for the June quarter (Q1FY24). The stock of pesticides & agrochemicals company was trading at its lowest level since March 2021. Thus… Continue reading UPL slips 5%, hits over 2-year low on weak June quarter results